Nuvig
4 known investors
Nuvig Therapeutics develops immune-modulating medicines for autoimmune diseases by harnessing endogenous regulatory mechanisms to resolve immune dysregulation. The company targets patients with chronic inflammatory and autoimmune conditions.
BiotechHealthtechMedical Devices
Investors · 4
In the news
- The Week’s Biggest Funding Rounds: Tenstorrent And Nuvig Top Listnews.crunchbase.com · 2024
- Nuvig pulls in $161M to make better immune drugs | BioPharma Divebiopharmadive.com · 2024
- Nuvig raises $161M with 4 Big Pharmas in towfiercebiotech.com · 2024
- Nuvig raises $161M as it prepares for Phase 2 study in hot autoimmune fieldendpoints.news · 2024
- Nuvig Therapeutics Raises $161M in Series B Fundingfinsmes.com · 2024
- Team | Nuvig Therapeuticsnuvigtx.com · 2022